WINDTREE THERAPEUTICS INC /DE/ Restricted Cash and Cash Equivalents
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Restricted Cash and Cash Equivalents of $225.00 thousand as of 2014-12-31, per its 10-K filed 2015-03-16.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2015-03-16
- 2014-12-31: Restricted Cash and Cash Equivalents $225.00K.
- 2013-12-31: Restricted Cash and Cash Equivalents $325.00K.
- 2012-12-31: Restricted Cash and Cash Equivalents $400.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2014-12-31 | $225.00K 10-K · filed 2015-03-16 |
| 2013-12-31 | $325.00K 10-K · filed 2014-03-17 |
| 2012-12-31 | $400.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |